47th Provincial Quality Control Board meeting: FIRs to be registered against spurious drug makers
* Board reviews working of drug inspectors and Drug Testing Laboratory
LAHORE: The Provincial Quality Control Board (PQCB) on Thursday permitted the police to register First Information Reports (FIRs) under the provisions of the Drug Act 1976 against spurious drug manufacturers, besides rejecting the review petitions.
This decision was taken in the 47th PQCB meeting. Health secretary Anwaar Ahmad Khan presided over the meeting. PQCB secretary Saeed Anwar, Professor Naveed Ansari and Professor Mehboob-e-Rabbani were also present on the occasion.
The PQCB secretary told the meeting that the board had reviewed the quality control situation in the province. The Board also reviewed the working of the drug inspectors and the Drug Testing Laboratory Punjab.
The board permitted the police to register cases against Karamat Ali and Muhammad Saeed, residents of Faisalabad, involved in illegal drug manufacturing; Shakeel Ahmad and Haji Hussain, residents of Kasur, involved in manufacturing of spurious antibiotics; Afzal Ali, a resident of Kasur, involved in sale/manufacturing of spurious Amoxycillin capsules; Muhammad Anwar, owner of Al-Saudia Tibbi Foundation; Nasrullah, a resident of Bahawalpur, involved in manufacturing/selling of ‘so-called’ herbal Majoon Jinsing and Majoon Machhli; Muhammad Asif Zikriya, a resident of Sargodha, for selling spurious Clomid tablet; Asmat Farooq, a resident of Gujranwala, for keeping in possession ‘so-called’ herbal drug Nan-Bao; Tasadduq Hussain, a resident of Lahore, for selling unregistered drugs.
The board rejected the review petitions of Ziauddin, Muhammad Iqbal and Khurram Shahzad, against the findings of the Federal Investigation Agency and the drug inspector. The drug inspector was directed to launch the case of the Drug Court Lahore for trial. The Board also rejected the review petitions of Muhammad Sajid, Sajad Ahmad and Hafiz Muhammad Faisal against the drug inspector, who was ordered to launch the complaint under Section 23 of the Drug Act 1976. The accused were found selling spurious Ceporex suspension. The board also upheld its decision of prosecution in another case of selling active pharmaceuticals that had been stored illegally, he added.
The board also allowed the prosecution of Amjad Ali and Muhammad Akram (of a leading drug company) in the Drug Courts for their involvement in the manufacture of misbranded antibiotic injections; M/S Z-Jans Pharmaceutical Industries, Peshawar, for the selling/production of substandard Cesef suspension. The syrup was declared substandard by the Drug Testing Laboratory and the National Institute of Health.
The board also recommended the prosecution of M/s Friends Pharma, Lahore, for producing substandard Vioxime antibiotic suspension; M/s Nizam Cotton Industries, Wazirabad, for producing substandard Absorbent Cotton Wool, used in surgery.
The Board allowed prosecution of a Holland-based multinational firm, involved in the import of misbranded injections for anesthesia (for small children).
It was decided to approach the Health Ministry for the cancellation of drug registration in Pakistan. In another case M/s Chishti Pharmaceutical Laboratories was prosecuted.
The boards also allowed the prosecution of Adnan Hayee of Fareedi Medical Store, Jampur, in the Multan Drug Court, involved in a case of keeping substandard antibiotic suspensions for children’s use. The board also directed the drug inspector and the executive district officer to cancel the licence and seal the premises of the accused.